Pharma Case Study: Merck’s $11.5B acquisition of Acceleron
Posted on03 Oct 2021
Comments0
Merck will acquire Acceleron Pharma, Inc. XLRN for $180 per share in cash for an approximate total equity value of $11.5 billion... Read More
Sanofi Bangladesh Limited’s majority stake is acquired by Beximco Pharma, Bangladesh
Beximco Pharmaceuticals Limited, one of leading pharmaceutical company based at Bangladesh, have completed its acquisition of the majority stake (54.6%) in Sanofi... Read More
RIL arm acquires stake in Strand Life Sciences for Rs. 393 crore
Reliance Strategic Business Ventures Limited, a wholly owned subsidiary of Reliance Industries Limited has acquired stake in Strand Life Sciences for a... Read More
DRL enters agreement to sell its rights to anti-cancer agent E7777 to Citius Pharma
Dr Reddy’s Laboratories Ltd announced that it has entered into a definitive agreement with Citius Pharmaceuticals, Inc. pursuant to which it sold... Read More
Takeda and Frazier announced a collaboration to launch HilleVax, Inc, a biopharmaceutical company, to develop and commercialize Takeda’s norovirus vaccine candidate
Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners announced a collaboration to launch HilleVax, Inc, a biopharmaceutical company, to develop and commercialize... Read More
Case Insight: Piramal Pharma’s acquisition of Hemmo Pharmaceuticals
Piramal Pharma Ltd has completed the acquisition of Hemmo Pharmaceuticals. In March this year, Piramal Pharma Ltd entered into an agreement to... Read More
Rossari Biotech to acquire Tristar Intermediates
Rossari Biotech Ltd, a speciality chemicals manufacturer, on Sunday announced the acquisition of Tristar Intermediates at an enterprise value of Rs 120... Read More
FDA Grants Accelerated Approval for Alzheimer’s drug Aduhelm
Posted on10 Jun 2021
Tagsaducanumab, Aduhelm, Biogen, Eisai, global pharma licensing deal, monoclonal antibody, Neurimmune, pharma deal
Comments0
USFDA approved Aduhelm (aducanumab) for the treatment of Alzheimer disease. Alzheimer’s drug Aduhelm is research molecule of Neurimmune. Neurimmune licensed its antibody... Read More
Insight on Neurogastrx licensing deal with Daewoong Pharmaceutical to Develop Fexuprazan
Neurogastrx, Inc. has entered into an exclusive license agreement with Daewoong Pharmaceutical Co., Ltd., of Seoul, South Korea, for the development and... Read More
Corbus Pharma in-licenses two integrin targeting MAbs
US biotech Corbus Pharmaceuticals (Nasdaq: CRBP) today announced the expansion of its portfolio into immuno-oncology through licensing deals for two new monoclonal... Read More